Lifecore Biomedical to be acquired by Webster Equity Partners for up to $663.7M

Lifecore Biomedical has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, including contingent value rights. Common stockholders will receive $6.28 per share in cash.

“Lifecore is approaching an exciting inflection point, with the potential for numerous programs to commercialize by the end of 2028.”globenewswire.com

• 3 sources
• globenewswire.comLifecore Biomedical to be Acquired by Webster EquityLifecore Biomedical, Inc.Sep 28, 2026
• ir.lifecore.comLifecore Biomedical to be Acquired by Webster Equity Partners | Lifecore BiomedicalSep 28, 2026
• app.readthrough.bioLifecore Biomedical agrees to Webster Equity Partners buyout, extends Alcon manufacturing deal to 2034 | readthroughSep 29, 2026

Summarized from public sources; check the original articles before acting on it.